#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Wolfram syndrome Antiphospholipid syndrome Necrotising myositis Brain abscess Pustular psoriasis Loeys-Dietz syndrome Pleural mesothelioma malignant Hormone-dependent prostate cancer Oesophageal squamous cell carcinoma stage III Craniocerebral injury Aspergillus infection Inclusion body myositis Retinopathy proliferative C3 glomerulopathy More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Diagnostics Noonan syndrome Systemic sclerosis pulmonary – Trials in Disease Hereditary angioedema – Basic Information Fabry’s disease – Basic Information Adrenocortical carcinoma – Trials in Disease IgA nephropathy – Trials in Disease Hereditary motor and sensory neuropathy – Trials in Disease Noonan syndrome – Basic Information Isodicentric chromosome 15 syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amlodipine Besilate Tedizolid Phosphate Radium Ra 223 Dichloride Nacystelyn Osimertinib Sodium Zirconium Cyclosilicate Bifikafusp Alfa Progesterone, Micronised Polydextrose Belimumab Melphalan Hydrochloride Teprenone Glycerol Phenylbutyrate Stx-241 Atorvastatin Tulisokibart Grwd5769 Gozetotide Alf-18 Dipyridamole HYDROGEN More therapies…

    Learn about Your Condition

    Desmoid tumour ROHHAD syndrome Hodgkin's disease Huntington's disease Undifferentiated sarcoma Spinal cord injury Prolymphocytic leukaemia Nicotine dependence Diphtheria Ventricular fibrillation Anaemia of pregnancy Anaplastic thyroid cancer Petit mal epilepsy Bone sarcoma Hypoglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Total-Body PET with [18F]Flutemetamol in Patients with Post-COVID Syndrome (Long COVID)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Flutemetamol (18F)
    The Netherlands

  • RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Belgium Czechia France Germany Hungary Italy +3

  • A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments

    Recruiting

    2 1
    Spain

  • Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis

    Recruiting

    3 1
    Investigated Diseases:
    • Eczema
    • Dermatitis atopic
    Investigated Drugs:
    • Lebrikizumab
    Czechia France Germany Poland Spain

  • Long-Term Study of Imeroprubart in Adults With Graves’ Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • IMEROPRUBART
    Belgium Bulgaria Czechia Germany Greece Hungary +5

  • Early Stopping of Antibiotic Treatment in Children with Cancer and Febrile Neutropenia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Amikacin
    • Cefepime
    • Ciprofloxacin
    Spain
Previous Page
1 … 17 18 19 20 21 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!